Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rothman

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Bulletin of the History of Medicine|November 1, 1972
De Laguna's commentaries on hallucinogenic drugs and witchcraft in Dioscorides' Materia MediaT Rothman
Science (New York, N.Y.)|November 22, 1991
A center for scienceT Rothman
British Medical Journal|March 29, 1980
Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapyM T Rothman
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment optionsMartin T Rothman
Environmental Letters|January 1, 1975
Droplet size of cooling tower fogT Rothman, J O Ledbetter
The British Journal of Clinical Practice|January 1, 1991
Coronary artery spasmM T Rothman, B Khan
BMJ (Clinical Research Ed.)|January 16, 2007
Stent thrombosis: patient card on discontinuing clopidogrel is availableSotiris Antoniou, Martin T Rothman
Journal of Interventional Cardiology|November 25, 2003
Antiproliferative coatings for the treatment of coronary heart disease:. what are the targets and which are the tools?Elliot J Smith, Martin T Rothman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 21, 2012
Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five RegistryMartin T Rothman, Ajay K Jain,
Pacing and Clinical Electrophysiology : PACE|November 1, 1984
Clinical results with Omni-Orthocor, an implantable antitachycardia pacing systemM T Rothman, J M Keefe
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Bulletin of the History of Medicine|November 1, 1972
De Laguna's commentaries on hallucinogenic drugs and witchcraft in Dioscorides' Materia MediaT Rothman
Science (New York, N.Y.)|November 22, 1991
A center for scienceT Rothman
British Medical Journal|March 29, 1980
Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapyM T Rothman
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment optionsMartin T Rothman
Environmental Letters|January 1, 1975
Droplet size of cooling tower fogT Rothman, J O Ledbetter
The British Journal of Clinical Practice|January 1, 1991
Coronary artery spasmM T Rothman, B Khan
BMJ (Clinical Research Ed.)|January 16, 2007
Stent thrombosis: patient card on discontinuing clopidogrel is availableSotiris Antoniou, Martin T Rothman
Journal of Interventional Cardiology|November 25, 2003
Antiproliferative coatings for the treatment of coronary heart disease:. what are the targets and which are the tools?Elliot J Smith, Martin T Rothman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 21, 2012
Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five RegistryMartin T Rothman, Ajay K Jain,
Pacing and Clinical Electrophysiology : PACE|November 1, 1984
Clinical results with Omni-Orthocor, an implantable antitachycardia pacing systemM T Rothman, J M Keefe
Pageof 9